相关实验视频
Updated: Mar 6, 2026

14:15
A Heterotopic Mouse Model for Studying Laryngeal Transplantation
Published on: January 13, 2023
3.3K
系统性免疫抑制,以减少ANCA阴性亚结节狭窄症的手术干预
Guy Benshetrit1,2, Stephen McAdoo2,3, Romana Kuchai1,2
1National Centre for Airway Reconstruction, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK.
The Laryngoscope
|March 4, 2026
概括
系统性免疫抑制与手术相结合,可能会改善患有侵袭性异常性小结肠狭窄症 (iSGS) 和多炎颗粒炎症 (GPA-SGS) 的患者的治疗结果. 这种方法可以延长无疾病间隔,为管理这种具有挑战性的呼吸道状况提供了新的希望.
科学领域:
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 异常性小结节狭窄症 (iSGS) 由于其不清楚的病因和反复性质,提出了临床挑战.
- 目前的治疗主要依赖于手术扩张,往往在一小部分患者中产生低于最佳的长期结果.
- 侵袭性形式的小结节狭窄症 (SGS) 需要探索除了手术之外的辅助疗法.
研究的目的:
- 评估系统性免疫抑制的疗效,作为侵略性iSGS和多炎SGS (GPA-SGS) 颗粒瘤症患者的手术管理的辅助.
- 评估免疫抑制治疗对这些患者队列的疾病活性和间扩张间隔 (IDI) 的影响.
主要方法:
- 在第三级呼吸道中心对孤立SGS患者的回顾性分析.
- 队列分类为iSGS,GPA-SGS,以及被称为"非典型-SGS"的侵略性iSGS的子队列.
- 在非典型的SGS和GPA-SGS队列中,与手术一起进行了系统性免疫抑制;治疗前后通过IDI监测疾病活性.
主要成果:
- 该研究包括60名患者:33名iSGS,20名GPA-SGS和7名非典型SGS.
- 异常性SGS患者表现出无免疫抑制的惰性过程 (中位数IDI:17.6个月).
- 与治疗前的间隔 (p<0.05) 相比,GPA-SGS和非典型SGS队列在免疫抑制后 (分别为26.0个月和27.8个月) 显示显著延长的IDI.
- 免疫抑制疗法没有报告任何重大不良事件.
结论:
- 非典型的SGS代表了SGS的一个独特的,积极的亚型,需要量身定制的管理.
- 系统性免疫抑制,通常用于GPA,有效地延长了GPA-SGS和非典型SGS的无疾病间隔.
- 研究结果支持考虑用于频繁复发的ANCA阴性SGS的免疫疗法,强调多学科护理.
相关概念视频
Mitral Stenosis III: Medical Management
390
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
390
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.8K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.8K
Chronic Pharyngitis
13.6K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
13.6K
Tonsillitis II: Management
495
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
495
Esophageal Strictures-II: Clinical Features and Management
801
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
801

